Accelerated apoA-I catabolism with decreased apoA-II production patients with end-stage renal disease: Stable isotope studies

被引：0
|
作者：
Ikewaki, K
Schaefer, JR
Okubo, K
Schwarz, S
Kronenberg, F
Schweer, H
Koenig, P
Hosoya, T
Mochizuki, S
Dieplinger, H
机构：
[1] Jikei Univ, Div Cardiol, Sch Med, Tokyo, Japan
[2] Univ Marburg, Dept Internal Med Cardiol, Marburg, Germany
[3] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan
[4] Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria
[5] Univ Marburg, Childrens Hosp, Marburg, Germany
[6] Univ Innsbruck, Dept Clin Nephrol, A-6020 Innsbruck, Austria
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
622
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [1] SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
    de Beer, MC
    van der Westhuyzen, DR
    Whitaker, NL
    Webb, NR
    de Beer, FC
    JOURNAL OF LIPID RESEARCH, 2005, 46 (10) : 2143 - 2150
  • [2] Sites of catabolism of apoA-I and apoA-II using Tyramine Cellobiose in control mice and mice with genetic dyslipoproteinemias
    Lambert, G
    Amar, MJ
    Shamburek, RD
    Cain, WJ
    Santamarina-Fojo, S
    Brewer, HB
    CIRCULATION, 2001, 104 (17) : 269 - 269
  • [3] Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice -: Possible role of leptin in stimulation of HDL turnover
    Silver, DL
    Jiang, XC
    Tall, AR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) : 4140 - 4146
  • [4] SIMULTANEOUS DETERMINATION OF APOB-100, APOA-I AND APOA-II SYNTHETIC RATE BY STABLE ISOTOPE TECHNIQUE IN HUMAN-SUBJECTS
    GHISELLI, G
    HACHEY, DL
    WITTELS, E
    GOTTO, AM
    KLEIN, PD
    CLINICAL RESEARCH, 1988, 36 (03): : A278 - A278
  • [5] ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity
    Verges, Bruno
    Adiels, Martin
    Boren, Jan
    Barrett, Peter Hugh
    Watts, Gerald F.
    Chan, Dick
    Duvillard, Laurence
    Soderlund, Sanni
    Matikainen, Niina
    Kahri, Juhani
    Lundbom, Nina
    Lundbom, Jesper
    Hakkarainen, Antti
    Aho, Serge
    Simoneau-Robin, Isabelle
    Taskinen, Marja-Riitta
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04): : 1398 - 1406
  • [6] HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease
    Kuchta, Agnieszka
    Strzelecki, Adrian
    Cwiklinska, Agnieszka
    Gruchala, Marcin
    Zdrojewski, Zbigniew
    Kortas-Stempak, Barbara
    Wieczorek, Ewa
    Gliwinska, Anna
    Dabkowski, Iamil
    Jankowski, Maciej
    JOURNAL OF CARDIOLOGY, 2017, 69 (3-4) : 523 - 528
  • [7] Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate
    Taskinen, Marja-Riitta
    Sullivan, David R.
    Ehnholm, Christian
    Whiting, Malcolm
    Zannino, Diana
    Simes, R. John
    Keech, Anthony C.
    Barter, Philip J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (06) : 950 - U436
  • [8] Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
    S. S. Soedamah-Muthu
    H. M. Colhoun
    M.-R. Taskinen
    B. Idzior-Walus
    J. H. Fuller
    Diabetologia, 2000, 43 : 1353 - 1359
  • [9] Differences in HDL-cholesterol:apoA-I plus apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
    Soedamah-Muthu, SS
    Colhoun, HM
    Taskinen, MR
    Idzior-Walus, B
    Fuller, JH
    DIABETOLOGIA, 2000, 43 (11) : 1353 - 1359
  • [10] MARKEDLY ACCELERATED CATABOLISM OF APOLIPOPROTEIN A-II (APOA-II) AND HIGH-DENSITY-LIPOPROTEINS CONTAINING APOA-II IN CLASSIC LECITHIN - CHOLESTEROL ACYLTRANSFERASE DEFICIENCY AND FISH-EYE DISEASE
    RADER, DJ
    IKEWAKI, K
    DUVERGER, N
    SCHMIDT, H
    PRITCHARD, H
    FROHLICH, J
    CLERC, M
    DUMON, MF
    FAIRWELL, T
    ZECH, L
    SANTAMARINAFOJO, S
    BREWER, HB
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01): : 321 - 330
12345